As transformational as the pacemaker was, Martha believes a new Medtronic procedure, just approved by the FDA, will be even ...

Medtronic PLC closed $1.63 below its 52-week high ($91.49), which the company achieved on September 4th.

While it may not be enough for some shareholders, we think it is good to see the Medtronic plc ( NYSE:MDT ) share ...

Earnings announcement expected in 57 days. 20-year pro options trader reveals his one-line chart technique that shows when to ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in is favor in a patent dispute with Medtronic ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

Medtronic may be an underrated beneficiary of declining interest rates. That's because as rates come down, it becomes less ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...